Cat allergen vaccine - ImmuLogicAlternative Names: Allervax cat vaccine
Latest Information Update: 16 Jan 2001
At a glance
- Originator ImmuLogic Pharmaceutical
- Class Allergy immunotherapies; Antiallergics
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hypersensitivity
Most Recent Events
- 16 Jan 2001 Discontinued-III for Allergy in USA (Unknown route)
- 01 Dec 1997 Suspended-III for Allergy in USA (Unknown route)
- 16 Jul 1996 A clinical study has been added to the Vaccines therapeutic trials section (Pharmaceutical Approvals Monthly 1996 Jun: 50)